Furthermore, a recent study demonstrated that endothelial dysfunction can be corrected with vitamin B12 and folic acid treatments in patients with both homozygous MTHFR C677T mutations and vitamin B12 deficiency (with hyperhomocysteinemia) [5]. This evidence concerns the gene MTHFR and endothelial dysfunction.